Excellent
Excellent Alignment
Patient Risk:
Low
Summary
All evaluated claims about dairy/calcium interactions and dosing timing are supported by the provided label sections (Drug Interactions, Pharmacokinetics, Dosage and Administration, Pediatric Use, and Patient Counseling Information), resulting in an Excellent alignment.
Category Scores
Accurate Statements
Ciprofloxacin can bind to minerals found in dairy (especially calcium).
7. Drug Interactions; 12.3 Pharmacokinetics
That binding can reduce how much of the antibiotic your body absorbs, which can make treatment less effective.
7. Drug Interactions; 12.3 Pharmacokinetics
Calcium-rich items can include cheese and other dairy products.
7. Drug Interactions
People are advised to avoid taking ciprofloxacin at the same time as calcium-fortified drinks or calcium supplements because they can have the same absorption problem.
7. Drug Interactions; 2. Dosage and Administration
A common practical approach is to take ciprofloxacin 2 hours before or 6 hours after dairy/calcium products.
2. Dosage and Administration; 7. Drug Interactions
This timing reduces the chance of binding in the gut and lowering absorption.
7. Drug Interactions; 12.3 Pharmacokinetics
If you already had dairy close to your dose, follow the separation timing above for the next dose.
2. Dosage and Administration
If you are unsure how close your last dairy intake was, consult a pharmacist for guidance based on your exact schedule and formulation.
17. Patient Counseling Information; 7. Drug Interactions
The same absorption issue applies to children taking ciprofloxacin.
8.4 Pediatric Use; 7. Drug Interactions; 12.3 Pharmacokinetics
Parents typically separate ciprofloxacin doses from dairy using the same time-gap guidance.
2. Dosage and Administration; 17. Patient Counseling Information
Parents discuss questions about the child’s dosing schedule with a clinician or pharmacist.
17. Patient Counseling Information
The dairy/calcium interaction is based on ciprofloxacin absorption, so it can apply across common oral forms.
7. Drug Interactions; 12.3 Pharmacokinetics
Use the separation timing with the specific product you are taking and follow the directions on your prescription label.
2. Dosage and Administration; 17. Patient Counseling Information
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
Claims focus on administration timing to preserve absorption and are corroborated by label sections; no new safety risks identified beyond documented interactions with polyvalent cations.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Excellent Alignment
Primary Issue
Suggested Improvement